U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07229599) titled 'A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer' on Nov. 13.
Brief Summary: This is a first-in-human, open-label, multicenter Phase I/II study of MHB036C combined with MHB039A or other anti-tumor therapy in patients with advanced lung cancer. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB036C combined with MHB039A or other anti-tumor therapies.
Study Start Date: May 09
Study Type: INTERVENTIONAL
Condition:
Advanced Lung Cancer
Intervention:
DRUG: MHB036C for Injection
IV administration; Participants will continue t...